BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zollers B, Huebner M, Armintrout G, Rausch-derra LC, Rhodes L. Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite. J vet Pharmacol Therap 2017;40:248-55. [DOI: 10.1111/jvp.12358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wofford JA, Zollers B, Rhodes L, Bell M, Heinen E. Evaluation of the safety of daily administration of capromorelin in cats. J vet Pharmacol Therap 2018;41:324-33. [DOI: 10.1111/jvp.12459] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Zollers B, Rhodes L, Smith RG. Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs. J vet Pharmacol Therap 2017;40:140-7. [DOI: 10.1111/jvp.12344] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
3 Zollers B, Rhodes L, Heinen E. Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. BMC Vet Res 2017;13:10. [PMID: 28056951 DOI: 10.1186/s12917-016-0925-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Rhodes L, Zollers B, Wofford JA, Heinen E. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Vet Med Sci 2018;4:3-16. [PMID: 29468076 DOI: 10.1002/vms3.83] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Smith AJ. Perspectives on Feeding and Nutrition. Vet Clin North Am Small Anim Pract 2019;49:501-17. [PMID: 30850306 DOI: 10.1016/j.cvsm.2019.01.014] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Freeman LM. Cachexia and Sarcopenia in Companion Animals: An Under-Utilized Natural Animal Model of Human Disease. JCSM Rapid Communications 2018;1:1-17. [DOI: 10.1002/j.2617-1619.2018.tb00006.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pascutti K, O'kell A, Hill R, Castro R, Salute M, Gilor C. The effect of capromorelin on glycemic control in healthy dogs. Domestic Animal Endocrinology 2022. [DOI: 10.1016/j.domaniend.2022.106732] [Reference Citation Analysis]
8 Johannes CM, Musser ML. Anorexia and the Cancer Patient. Vet Clin North Am Small Anim Pract 2019;49:837-54. [PMID: 31176457 DOI: 10.1016/j.cvsm.2019.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Zollers B, Wofford JA, Heinen E, Huebner M, Rhodes L. A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite. J Vet Intern Med 2016;30:1851-7. [PMID: 27859746 DOI: 10.1111/jvim.14607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]